PRELI domain containing 3B pseudogene 2 (PRELID3BP2)

PRELI domain containing 3B pseudogene 2 is a processed pseudogene, meaning it is a nonfunctional segment of DNA that closely resembles a functional gene but cannot produce a functional protein product. As a pseudogene, it lacks the necessary regulatory elements or is otherwise disrupted, so it is not transcribed or translated into a working protein. Pseudogenes such as PRELID3BP2 are not considered targets (e.g., receptors, enzymes, or transporters) for therapeutic intervention and have no known direct biological function, roles in disease, or drug interactions. Pseudogenes, including PRELID3BP2, are common in the genome and represent the remnants of once-functional genes that have acquired disabling mutations or have lost crucial regulatory sequences. They may be used as markers in evolutionary or comparative genomics studies, but are not directly relevant in therapeutic development or disease intervention. Some pseudogenes can occasionally regulate their functional paralogs via RNA mechanisms, but there is no evidence that PRELID3BP2 has such a role. Because PRELID3BP2 is a pseudogene and not a protein-coding or regulatory gene, there is no evidence for drug interaction, biomarker status, or adverse safety considerations. The entry is "incorrect" as a therapeutic target because pseudogenes generally lack direct functionality relevant to drug development or clinical targeting.

Other names

SLMO2P2SLMO2 pseudogene 2slowmo homolog 2 pseudogene 2PRELID3BP2